Mediaid Inc., the US subsidiary of Bangalore-based Opto Circuits (I) Ltd. (OCI) has received an approval from the Food and Drug Administration (FDA) to market its SpO2 Sensor in the United States. | |
| OCI acquired the patient monitoring division of Palco Labs, USA in January 2003 and renamed it Mediaid Inc. |
| |
| SpO2 is an advanced non-invasive oximeter used to measure the level of oxygen saturation in the blood and pulse rate monitoring. |
| |
| The Mediaid SpO2 is part of a revolutionary technology platform that improved the flexibility of the patient monitoring system in hospital emergency/operating rooms, to meet the ever-changing clinical needs of the dynamic healthcare environment. |
| |
| Mediaid products use digital signal processing technology to calculate a patient's pulse rate and the functional saturation of arterial oxygen. |
| |
| The annual worldwide demand for the product is estimated to be $0.5 billion of which 70 per cent is from the US market itself. |
| |
| The FDA clearance opens immense business opportunity for OCI as their cost-efficient operations in India allows Mediaid SpO2 to be offered for sale in the competitive US market at a significantly lower price. |
| |
|
| |
